Pulmonary Arterial Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
Research paves way for new treatment to protect people from cardiovascular disease

Research paves way for new treatment to protect people from cardiovascular disease

Patients receiving drug therapy before LVAD implantation have high risk of right-sided heart failure

Patients receiving drug therapy before LVAD implantation have high risk of right-sided heart failure

Owlstone Medical announces strategic collaboration with Actelion to improve lives of people with pulmonary hypertension

Owlstone Medical announces strategic collaboration with Actelion to improve lives of people with pulmonary hypertension

EuroCMR 2019 to present novel studies on clinical use of cardiovascular magnetic resonance

EuroCMR 2019 to present novel studies on clinical use of cardiovascular magnetic resonance

Trio Health introduces new TH-PAH database for patients with pulmonary arterial hypertension

Trio Health introduces new TH-PAH database for patients with pulmonary arterial hypertension

Researchers identify new diagnostic clues for life-limiting lung condition

Researchers identify new diagnostic clues for life-limiting lung condition

The high cost of sex: Insurers often don’t pay for drugs to treat problems

The high cost of sex: Insurers often don’t pay for drugs to treat problems

CHEST updates guidelines on therapy for pulmonary arterial hypertension

CHEST updates guidelines on therapy for pulmonary arterial hypertension

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

New study finds that pregnancy is safe for most women with heart disease

New study finds that pregnancy is safe for most women with heart disease

Pregnant women with heart disease must give birth at 40 weeks gestation

Pregnant women with heart disease must give birth at 40 weeks gestation

Scientists identify drug that could reverse pulmonary arterial hypertension

Scientists identify drug that could reverse pulmonary arterial hypertension

CVIA publishes special issue on adult congenital heart disease

CVIA publishes special issue on adult congenital heart disease

NUS researchers find novel pathway to regulate blood pressure

NUS researchers find novel pathway to regulate blood pressure

ATS Foundation and Insmed to provide $50,000 funding for NTM lung disease research

ATS Foundation and Insmed to provide $50,000 funding for NTM lung disease research

Generic versions of Viagra coming this week

Generic versions of Viagra coming this week

Inflammatory processes triggered by lung cancer could cause pulmonary hypertension

Inflammatory processes triggered by lung cancer could cause pulmonary hypertension

Low-energy ESWT shows promise for managing digital ulcers in patients with systemic sclerosis

Low-energy ESWT shows promise for managing digital ulcers in patients with systemic sclerosis

Common heart disease medication may help treat pulmonary arterial hypertension

Common heart disease medication may help treat pulmonary arterial hypertension

New chemoprevention trial hopes to stop dangerous lesions from progressing to cancer

New chemoprevention trial hopes to stop dangerous lesions from progressing to cancer